Target intelligence / Profile preview

long intergenic non-protein coding RNA 2961 (LINC02961)

Target
LINC02961
Molecular classification
Other (specifically: long non-coding RNA)
01

Overview

Long intergenic non-protein coding RNA 2961 (LINC02961) is a human gene encoding a long non-coding RNA (lncRNA), classified as an intergenic non-protein coding RNA[1][3][5][7][9]. LINC02961 does not encode a protein and instead belongs to the family of long intergenic non-coding RNAs, molecules increasingly recognized as key regulators of gene expression at the transcriptional and epigenetic levels[10]. There is currently no evidence establishing LINC02961 as a direct therapeutic target, nor is there detailed functional annotation available for this particular lncRNA. However, lncRNAs as a class are of growing interest in oncology and developmental biology due to their roles in gene regulation, chromatin remodeling, and potentially in cancer progression[10]. LINC02961 is also known by the alias PP2672[1][5][9].

Other names
PP2672
02

Mechanism of action

None known

03

Biological functions

Regulation of gene expressionChromatin modification (by analogy with the functional class, not demonstrated specifically for LINC02961)Other (functions are largely uncharacterized for LINC02961 specifically)[10]
04

Disease associations

Other (potential, but uncharacterized; long intergenic non-coding RNAs in general have been implicated in cancer biology)[10]

Beyond the preview

Go deeper on long intergenic non-protein coding RNA 2961 (LINC02961).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on long intergenic non-protein coding RNA 2961 (LINC02961).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call